所有類別 The 3rd TASL-AALSD Joint SymposiumThe 4th TASL-AASLD joint symposiumThe 1st TASL-AASLD Joint Symposium: HBV EliminatioHepatocellular carcinomaTASL 2021 HCC Single Topic Conference-symposiumThe 2st TASL-AASLD Joint Symposium認識B肝與治療 The 4th TASL-AASLD joint symposium Risk stratification of MASLD-associate HCC 影片長度: The 4th TASL-AASLD joint symposium Advances in pediatric MASLD 影片長度: The 4th TASL-AASLD joint symposium Difference in the management of MetALD and Alcoholic liver disease 影片長度: The 4th TASL-AASLD joint symposium The impact of MASLD on outcomes in cured HCV patients 影片長度: The 4th TASL-AASLD joint symposium The impact of MASLD on natural history of chronic HBV infection 影片長度: The 3rd TASL-AALSD Joint Symposium Viral hepatitis, hepatocarcinogenesis, and lifelong care 影片長度: The 3rd TASL-AALSD Joint Symposium Emerging liver diseases: new virus or immune dysfunction 影片長度: The 3rd TASL-AALSD Joint Symposium Inherited liver diseases in children and young adults- from diagnosis to treatment 影片長度: The 3rd TASL-AALSD Joint Symposium Liver disease involving mothers and children: from HBV transmission to genetic diseases 影片長度: The 3rd TASL-AALSD Joint Symposium Towards elimination of viral hepatitis in Taiwan: our achievements and what else should be done? 影片長度: The 3rd TASL-AALSD Joint Symposium Path to hepatitis elimination: perspective on treatment and new standard of care 影片長度: 認識B肝與治療 認識B肝與治療 影片長度: Hepatocellular carcinoma Hepatocellular carcinoma 影片長度: TASL 2021 HCC Single Topic Conference-symposium How to optimize second-line HCC treatment 影片長度: Yi-Hsiang Huang TASL 2021 HCC Single Topic Conference-symposium TASL 2021 HCC Single Topic Conference-symposium 影片長度: Yi-Hsiang Huang 1 2 3 > 到最後 ,前往第 1 2 3 頁